Coronavirus non-structural protein 16: Evasion, attenuation, and possible treatments

Vineet D. Menachery, Kari Debbink, Ralph S. Baric

Research output: Contribution to journalReview articlepeer-review

47 Scopus citations


The recent emergence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV), nearly a decade after the Severe Acute Respiratory Syndrome (SARS) CoV, highlights the importance of understanding and developing therapeutic treatment for current and emergent CoVs. This manuscript explores the role of NSP16, a 2'O-methyl-transferase (2'O-MTase), in CoV infection and the host immune response. The review highlights conserved motifs, required interaction partners, as well as the attenuation of NSP16 mutants, and restoration of these mutants in specific immune knockouts. Importantly, the work also identifies a number of approaches to exploit this understanding for therapeutic treatment and the data clearly illustrate the importance of NSP16 2'O-MTase activity for CoV infection and pathogenesis.

Original languageEnglish (US)
Pages (from-to)191-199
Number of pages9
JournalVirus Research
StatePublished - Dec 19 2014
Externally publishedYes


  • 2'O-MTase
  • 2'O-Methyl-transferase
  • CoV
  • MDA5
  • NSP16
  • SARS-CoV

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases
  • Cancer Research


Dive into the research topics of 'Coronavirus non-structural protein 16: Evasion, attenuation, and possible treatments'. Together they form a unique fingerprint.

Cite this